At the 2026 @Philly Cell and Gene Therapy Annual Conference, Dr. Peter Marks highlighted how gene therapy science is surging ahead and called for smarter regulatory evolution to unlock treatments for thousands of rare disease patients.
- April 2026 — CDMO Opportunities And Threats Report
- Cell And Gene Therapies: The Emerging Reality For Scalable Market Readiness
- Tackling The Cell & Gene Therapy Sector's Practical Post-Approval Problem
- Why Your MES RFP Is Failing Before It Starts
- Here's How FDA's Accelerated Approval Pathway Has Evolved Since '24
- Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction
- Inside March Biosciences' CD5-Targeting CAR-T Approach
- Causal Mechanism And Effect Analysis (CMEA): FMEA's Simpler, Effective Alternative
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2103894533 office, team, coworkers, meeting]( "Enhance DMC Services By Harnessing Biostatistics Expertise")
Enhance DMC Services By Harnessing Biostatistics ExpertiseDiscover how expert biostatistics and project management ensured data integrity and efficient DMC operations in a complex clinical trial for hematologic cancer cell therapies.
-
![Labculture Shielded Biological Safety Cabinet]( "Shielded BSCs: Regulatory Requirement Or Risk-Based Engineering Solution?")
Shielded BSCs: Regulatory Requirement Or Risk-Based Engineering Solution?Master the balance between USP <825> aseptic standards and radiation safety. Learn how integrated engineering solutions ensure regulatory compliance while protecting both patients and personnel.
-
![GettyImages-1871216402-anaerobic-cultivation-of-probiotics]( "Anaerobic Cultivation Processes Of Probiotic Bacteria")
Anaerobic Cultivation Processes Of Probiotic BacteriaCultivate oxygen-sensitive probiotics with precision using real-time monitoring, microfluidic feeding, and pH control for reproducible growth and optimized microbiome and fermentation research.
-
![GettyImages-1181392775 lab, research]( "Navigating The Cell And Gene Regulatory Landscape")
Navigating The Cell And Gene Regulatory LandscapeNavigating the complex regulatory landscape is essential for cell and gene therapy success. Explore key considerations, challenges, and best practices for companies operating in this space.
-
![Molecule mRNA-GettyImages-1428646288]( "mRNA Therapeutic Development Through Enhanced IVT Capping Efficiency")
mRNA Therapeutic Development Through Enhanced IVT Capping EfficiencySee how Codex HiCap RNA Polymerase supports the production of high-performance synthetic mRNA, paving the way for next-generation mRNA therapies.
-
![GettyImages-1302640919-antibody]( "Overcoming Bispecific Antibody Purification Challenges")
Overcoming Bispecific Antibody Purification ChallengesEnhance the quality and safety of your BsAb therapeutics with a highly efficient with the right chromatography hydroxyapatite media.
-
![GettyImages-597971944-viral-vector-AAV-adeno-associated-virus]( "The Key To Viral Vector Success")
The Key To Viral Vector SuccessEstablishing a robust and scalable viral vector process requires a multidisciplinary approach that incorporates expertise in foundational science, analytics, and biomanufacturing.
-
![thermo bioreactor thumb]( "Scale-Up Approaches For Culturing Adherent Cells")
Scale-Up Approaches For Culturing Adherent CellsFor successful scale-up, see how optimizing process parameters such as attachment methods, gassing, and agitation can help reduce cell environmental stress, ultimately improving productivity.
-
![GettyImages-185246319 fluorescent DNA]( "CAR Expression Detection Using Fluorescent Labeled Proteins, Flow Cytometry")
CAR Expression Detection Using Fluorescent Labeled Proteins, Flow CytometryLearn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.
-
![GettyImages-1312272657 patient advocacy centricity]( "How Patient-Centric Approaches Are Shaping The Future Of CGT")
How Patient-Centric Approaches Are Shaping The Future Of CGTEmily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.
NEWSLETTER ARCHIVE
- 05.13.26 -- How MTP Is Transforming Pharma Production Lines
- 05.13.26 -- Rewriting Disease Biology Through LSD1 Inhibition
- 05.12.26 -- West Vantage: End-to-End Combination Product Solutions
- 05.12.26 -- STREAM Edition: Inside The Phased, Risk-Based Approach For CGT Materials
- 05.12.26 -- Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
- Sana, Mayo Clinic Advance A New Model For Cell Therapy Delivery In T1D
- Reprogramming T-Cell Access To Solid Tumors Through Improved Trafficking And Entry
- Target Selection Drives The Future Of CAR T Therapy In Solid Tumors
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
